Pro-necrotic molecules impact local immunosurveillance in human breast cancer

Necrosis culminates in spilling cellular content through the permeabilized plasma membrane, thereby releasing potentially immunostimulatory molecules in the pericellular space of dead cells. Accordingly, molecules involved in necroptotic signaling, such as receptor-interacting serine/threonine-prote...

Full description

Bibliographic Details
Main Authors: Gautier Stoll, Yuting Ma, Heng Yang, Oliver Kepp, Laurence Zitvogel, Guido Kroemer
Format: Article
Language:English
Published: Taylor & Francis Group 2017-04-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1299302
_version_ 1818139375493447680
author Gautier Stoll
Yuting Ma
Heng Yang
Oliver Kepp
Laurence Zitvogel
Guido Kroemer
author_facet Gautier Stoll
Yuting Ma
Heng Yang
Oliver Kepp
Laurence Zitvogel
Guido Kroemer
author_sort Gautier Stoll
collection DOAJ
description Necrosis culminates in spilling cellular content through the permeabilized plasma membrane, thereby releasing potentially immunostimulatory molecules in the pericellular space of dead cells. Accordingly, molecules involved in necroptotic signaling, such as receptor-interacting serine/threonine-protein kinase 3 (RIPK3) and mixed lineage kinase-like (MLKL) have been found to stimulate anticancer immune responses in mouse models of chemotherapy. mRNAs encoding prominent pro-necrotic gene products (RIPK1, RIPK3, MLKL, PGAM5 and DFNA5) were correlated with immune-related metagenes in several cancer types (breast, colorectal, lung, ovary, melanoma), revealing the strongest associations in breast cancer. In two independent breast cancer cohorts, the expression of MLKL and DFNA5 was decreased at the mRNA levels in tumor as compared with normal tissues. Moreover, MLKL expression exhibited a strong positive correlation with genes reflecting the presence of B, NK and T lymphocytes in the tumor bed, in multiple distinct breast cancer subtypes. In contrast, the positive correlation between RIPK3 and lymphoid cells was restricted to HER2+ and triple negative/basal-like breast cancer. Moreover, the expression of DFNA5, which mediates post-apoptotic secondary necrosis, mostly correlated with the monocytic lineage and macrophages in ER+/luminal A breast cancers. MLKL (and to some extent RIPK1 and RIPK3) was strongly associated with the local expression of genes involved in interferon-α and interferon-γ responses. Altogether, these results support the idea that pro-necrotic signaling facilitates intratumoral immune responses in human breast cancer.
first_indexed 2024-12-11T10:27:06Z
format Article
id doaj.art-6d4d8e8732ce4ea3abbfe9cba8b1d2e2
institution Directory Open Access Journal
issn 2162-402X
language English
last_indexed 2024-12-11T10:27:06Z
publishDate 2017-04-01
publisher Taylor & Francis Group
record_format Article
series OncoImmunology
spelling doaj.art-6d4d8e8732ce4ea3abbfe9cba8b1d2e22022-12-22T01:11:06ZengTaylor & Francis GroupOncoImmunology2162-402X2017-04-016410.1080/2162402X.2017.12993021299302Pro-necrotic molecules impact local immunosurveillance in human breast cancerGautier Stoll0Yuting Ma1Heng Yang2Oliver Kepp3Laurence Zitvogel4Guido Kroemer5Sorbonne Paris CitéSuzhou Institute of Systems MedicineSuzhou Institute of Systems MedicineSorbonne Paris CitéInstitut National de la Santé et de la Recherche MédicaleSorbonne Paris CitéNecrosis culminates in spilling cellular content through the permeabilized plasma membrane, thereby releasing potentially immunostimulatory molecules in the pericellular space of dead cells. Accordingly, molecules involved in necroptotic signaling, such as receptor-interacting serine/threonine-protein kinase 3 (RIPK3) and mixed lineage kinase-like (MLKL) have been found to stimulate anticancer immune responses in mouse models of chemotherapy. mRNAs encoding prominent pro-necrotic gene products (RIPK1, RIPK3, MLKL, PGAM5 and DFNA5) were correlated with immune-related metagenes in several cancer types (breast, colorectal, lung, ovary, melanoma), revealing the strongest associations in breast cancer. In two independent breast cancer cohorts, the expression of MLKL and DFNA5 was decreased at the mRNA levels in tumor as compared with normal tissues. Moreover, MLKL expression exhibited a strong positive correlation with genes reflecting the presence of B, NK and T lymphocytes in the tumor bed, in multiple distinct breast cancer subtypes. In contrast, the positive correlation between RIPK3 and lymphoid cells was restricted to HER2+ and triple negative/basal-like breast cancer. Moreover, the expression of DFNA5, which mediates post-apoptotic secondary necrosis, mostly correlated with the monocytic lineage and macrophages in ER+/luminal A breast cancers. MLKL (and to some extent RIPK1 and RIPK3) was strongly associated with the local expression of genes involved in interferon-α and interferon-γ responses. Altogether, these results support the idea that pro-necrotic signaling facilitates intratumoral immune responses in human breast cancer.http://dx.doi.org/10.1080/2162402X.2017.1299302apoptosisimmunogenic cell deathimmunosurveillancenecrosis
spellingShingle Gautier Stoll
Yuting Ma
Heng Yang
Oliver Kepp
Laurence Zitvogel
Guido Kroemer
Pro-necrotic molecules impact local immunosurveillance in human breast cancer
OncoImmunology
apoptosis
immunogenic cell death
immunosurveillance
necrosis
title Pro-necrotic molecules impact local immunosurveillance in human breast cancer
title_full Pro-necrotic molecules impact local immunosurveillance in human breast cancer
title_fullStr Pro-necrotic molecules impact local immunosurveillance in human breast cancer
title_full_unstemmed Pro-necrotic molecules impact local immunosurveillance in human breast cancer
title_short Pro-necrotic molecules impact local immunosurveillance in human breast cancer
title_sort pro necrotic molecules impact local immunosurveillance in human breast cancer
topic apoptosis
immunogenic cell death
immunosurveillance
necrosis
url http://dx.doi.org/10.1080/2162402X.2017.1299302
work_keys_str_mv AT gautierstoll pronecroticmoleculesimpactlocalimmunosurveillanceinhumanbreastcancer
AT yutingma pronecroticmoleculesimpactlocalimmunosurveillanceinhumanbreastcancer
AT hengyang pronecroticmoleculesimpactlocalimmunosurveillanceinhumanbreastcancer
AT oliverkepp pronecroticmoleculesimpactlocalimmunosurveillanceinhumanbreastcancer
AT laurencezitvogel pronecroticmoleculesimpactlocalimmunosurveillanceinhumanbreastcancer
AT guidokroemer pronecroticmoleculesimpactlocalimmunosurveillanceinhumanbreastcancer